The efficacy of the cerebral metabolic enhancers in the treatment of senile dementia.
D000368:Aged; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D003704:Dementia / Q000188:drug therapy*; D004088:Dihydroergotoxine / Q000627:therapeutic use; D006801:Humans; D002504:Meclofenoxate / Q000627:therapeutic use; D009257:Nafronyl / Q000627:therapeutic use; D010889:Piracetam / Q000031:analogs & derivatives / Q000627:therapeutic use; D011746:Pyrithioxin / Q000627:therapeutic use; D014749:Vincamine / Q000627:therapeutic use
D004088:Dihydroergotoxine; D009257:Nafronyl; D014749:Vincamine; D011746:Pyrithioxin; D002504:Meclofenoxate; D010889:Piracetam